Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Translational Stroke Research
Published in: Translational Stroke Research 3/2017

01-06-2017 | Commentary

Can Quality Improvement Tools Overcome the Translational Roadblock—the Vital Influence of the Researcher

Author: Serge Marbacher

Published in: Translational Stroke Research | Issue 3/2017

Login to get access

Excerpt

Both special issues “Challenges and Controversies in Translational Stroke Research, Part 1 and 2” provide an excellent overview of the methodological challenges encountered in the various stages of planning, implementation, and evaluation of preclinical stroke studies. The topics discussed do not apply solely to the field of stroke research, but to many other fields of translational science as well. This collection of articles by highly informed scientists clearly illustrates that a multitude of approaches and measures is needed to address bias in preclinical research in order to increase the translation of knowledge from basic science to clinical practice. …
Literature
1.
Boltze J, Wagner DC, Henninger N, Plesnila N, Ayata C. Phase iii preclinical trials in translational stroke research: community response on framework and guidelines. Transl Stroke Res. 2016;7:241–7.CrossRefPubMedPubMedCentral
2.
Ahnstedt H, McCullough LD, Cipolla MJ. The importance of considering sex differences in translational stroke research. Transl Stroke Res. 2016;7:261–73.CrossRefPubMed
3.
Becker KJ. Strain-related differences in the immune response: relevance to human stroke. Transl Stroke Res. 2016;7:303–12.CrossRefPubMed
4.
Kent TA, Mandava P. Embracing biological and methodological variance in a new approach to pre-clinical stroke testing. Transl Stroke Res. 2016;7:274–83.CrossRefPubMed
5.
Ergul A, Hafez S, Fouda A, Fagan SC. Impact of comorbidities on acute injury and recovery in preclinical stroke research: focus on hypertension and diabetes. Transl Stroke Res. 2016;7:248–60.CrossRefPubMed
6.
Hoffmann U, Sheng H, Ayata C, Warner DS. Anesthesia in experimental stroke research. Transl Stroke Res. 2016;7:358–67.CrossRefPubMed
7.
Hommel M, Detante O, Favre I, Touze E, Jaillard A. How to measure recovery? Revisiting concepts and methods for stroke studies. Transl Stroke Res. 2016;7:388–94.CrossRefPubMed
8.
9.
Jolkkonen J, Kwakkel G. Translational hurdles in stroke recovery studies. Transl Stroke Res. 2016;7:331–42.CrossRefPubMed
10.
Richter SH, Garner JP, Wurbel H. Environmental standardization: cure or cause of poor reproducibility in animal experiments? Nat Methods. 2009;6:257–61.CrossRefPubMed
11.
Baker D, Lidster K, Sottomayor A, Amor S. Two years later: journals are not yet enforcing the arrive guidelines on reporting standards for pre-clinical animal studies. PLoS Biol. 2014;12:e1001756.CrossRefPubMedPubMedCentral
12.
Reichlin TS, Vogt L, Wurbel H. The researchers’ view of scientific rigor-survey on the conduct and reporting of in vivo research. PLoS One. 2016;11:e0165999.CrossRefPubMedPubMedCentral
13.
Stroke Therapy Academic Industry R. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30:2752–8.CrossRef
14.
Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M, Consortium SV. Stroke therapy academic industry roundtable (stair) recommendations for extended window acute stroke therapy trials. Stroke. 2009;40:2594–600.CrossRefPubMedPubMedCentral
15.
Stem Cell Therapies as an Emerging Paradigm in Stroke P. Stem cell therapies as an emerging paradigm in stroke (steps): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke. 2009;40:510–5.CrossRef
16.
Savitz SI, Chopp M, Deans R, Carmichael T, Phinney D, Wechsler L, et al. Stem cell therapy as an emerging paradigm for stroke (steps) ii. Stroke. 2011;42:825–9.CrossRefPubMed
17.
Lapchak PA, Zhang JH, Noble-Haeusslein LJ. Rigor guidelines: escalating stair and steps for effective translational research. Transl Stroke Res. 2013;4:279–85.CrossRefPubMed
18.
19.
Smith MM, Clarke EC, Little CB. Considerations for the design and execution of protocols for animal research and treatment to improve reproducibility and standardization: “Depart well-prepared and arrive safely”. Osteoarthritis Cartilage. 2016.
20.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the arrive guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.CrossRefPubMedPubMedCentral
21.
Hooijmans CR, Leenaars M, Ritskes-Hoitinga M. A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three rs, and to make systematic reviews more feasible. Altern Lab Anim. 2010;38:167–82.PubMed
22.
Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: it’s time to act. J Cereb Blood Flow Metab. 2012;32:933–5.CrossRefPubMedPubMedCentral
23.
Bath PM, Macleod MR, Green AR. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke. 2009;4:471–9.CrossRefPubMed
Metadata
Title
Can Quality Improvement Tools Overcome the Translational Roadblock—the Vital Influence of the Researcher
Author
Serge Marbacher
Publication date
01-06-2017
Publisher
Springer US
Published in
Translational Stroke Research / Issue 3/2017
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-017-0524-8

Other articles of this Issue 3/2017

Translational Stroke Research 3/2017 Go to the issue

Original Article

Sex Differences in the Cerebral Collateral Circulation

Original Article

Antiplatelet Strategies and Outcomes in Patients with Noncardioembolic Ischemic Stroke from a Real-World Study with a Five-Year Follow-Up

Original Article

Uric Acid Is Protective After Cerebral Ischemia/Reperfusion in Hyperglycemic Mice

Original Article

DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury

Original Article

Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage

Original Article

Long-Term Effect of Participation in an Early Exercise and Education Program on Clinical Outcomes and Cost Implications, in Patients with TIA and Minor, Non-Disabling Stroke